Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin

Journal of Nutritional Biochemistry

Volumn 21, Issue 8, 2010, Pages 726-735

  Rigacci, Stefania ^a   Guidotti, Valentina ^a   Bucciantini, Monica ^a,b   Parri, Matteo ^a   Nediani, Chiara ^a   Cerbai, Elisabetta ^a   Stefani, Massimo ^a,b   Berti, Andrea ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Research Center on the Molecular Basis of Neurodegeneration   (Italy)

Author keywords

Amylin; Amyloid cytotoxicity; Extra virgin olive oil; HIAPP; Oleuropein; Type two diabetes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLIN; AMYLOID; CASPASE 3; OLEUROPEIN; OLEUROPEIN AGLYCON; THIOFLAVINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MEMBRANE; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; LIPID VESICLE; MEMBRANE PERMEABILITY; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN AGGREGATION; PROTEIN INTERACTION; RAT;

AMYLOID; CELL LINE; CIRCULAR DICHROISM; HUMANS; ISLET AMYLOID POLYPEPTIDE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PYRANS;

EID: 77954661025     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.04.010     Document Type: Article

References (38)

1. Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003, 81:678-699.
2. Ludvik B., Kautzky-Willer A., Prager R., Thomaseth K., Pacini G. Amylin: history and overview. Diabet Med 1997, 14(Suppl 2):S9-S13.
3. Padrick S.B., Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 2002, 41:4694-4703.
4. Rocken C., Linke R.P., Saeger W. Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol 1992, 421:339-344.
5. Matveyenko A.V., Butler P.C. β-cell deficit due to increased apoptosis in the human Islet Amyloid Polypeptide Transgenic (HIP) rat recapitulates the metabolic defects present in Type 2 Diabetes. Diabetes 2006, 55:2106-2114.
6. Höppener J.W.M., Lips C.J. Role of Islet amyloid in Type 2 diabetes mellitus. Int J Biochem Cell Biol 2006, 38:726-736.
7. Ritzel R.A., Butler P.C. Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 2003, 52:1701-1708.
8. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75:333-366.
9. Haataja L., Gurlo T., Huang J., Butler P.C. Islet amyloid in Type 2 diabetes, and the toxic oligomer hypothesis. Endocrin Rev 2008, 29:303-316.
10. Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C.M., et al. Pre-fibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 2004, 279:31374-31382.
11. Butterfield A.D. Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002, 36:1307-1313.
12. Soler-Rivas C., Espin J.C., Wichers H.J. Oleuropein and related compounds. J Sci Food Agric 2000, 80:1013-1023.
13. Visioli F., Poli A., Galli C. Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 2002, 22:65-75.
14. Visioli F., Bellosta S., Galli C. Oleuropein, the bitter principles of olives, enhances nitric oxide production by mouse macrophages. Life Sci 1998, 62:541-546.
15. Carluccio M.A., Siculella L., Ancora M.A., Massaro M., Scoditti E., Storelli C., et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003, 23:622-629.
16. Owen R.W., Giacosa A., Hull W.E., Haubner R., Würtele G., Spiegelhalder B., et al. Olive oil consumption and health: the possible role of antioxidants. Lancet Oncol 2000, 1:107-112.
17. Andreadou I., Sigala F., Iliodromitis E.K., Papaefthimiou M., Sigalas C., Aligiannis N., et al. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol 2007, 42:549-558.
18. Andreadou I., Iliodromitis E.K., Mikros E., Constantinou M., Agalias A., Magiatis P., et al. The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 2006, 136:2213-2219.
19. Bazoti F.N., Bergquist J., Markides K.E., Tsarbopoulos A. Noncovalent interaction between amyloid-β-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 2006, 17:568-575.
20. Bazoti F.N., Bergquist J., Markides K., Tsarbopoulos A. Localization of the noncovalent binding site between amyloid-β-peptide and oleuropein using electrospray ionization FT-ICR mass spectrometry. J Am Soc Mass Spectrom 2008, 19:1078-1085.
21. Meier J.J., Kayed R., Lin C.Y., Gurlo T., Haataja L., Jayasinghe S.J., et al. Inhibition of human IAPP fibril formation does not prevent β-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 2006, 291:1317-1324.
22. Yan L.M., Tatarek-Nossol M., Velkova A., Kazantzis A., Kapurniotu A. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc Natl Acad Sci U S A 2006, 103:2046-2051.
23. Konno K., Hirayama C., Yasui H., Nakamura M. Enzymatic activation of oleuropein: a protein crosslinker used as chemical defence by privet tree. Proc Natl Acad Sci U S A 1999, 96:9159-9162.
24. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
25. Kayed R., Bernhagen J., Greenfield N., Sweimeh K.M., Brunner H., Voelter W., et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 1999, 287:781-796.
26. Porat Y., Mazor Y., Efrat S., Gazit E. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 2004, 43:14454-14462.
27. Bucciantini M., Rigacci S., Berti A., Pieri L., Cecchi C., Nosi D., et al. Patterns of cell death triggered in two different cell lines by HypF-N pre-fibrillar aggregates. FASEB J 2005, 19:437-449.
28. Engel M.F.M., Khemtémourian L., Kleijer C.C., Meeldijk H.J.D., Jacobs J., Verkleij A.J., et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci U S A 2008, 105:6033-6048.
29. LeVine H. Quantification of beta-sheet amyloid fibril structures with Thioflavine T. Methods Enzymol 1999, 309:274-284.
30. Khemtémourian L., Killian J.A., Höppener J.W.M., Engel M.F.M. Recent insight in Islet amyloid polypeptide-induced membrane disruption and its role in β-cell death in Type 2 diabetes mellitus. Exp Diabetes Res 2008, Article ID 421287.
31. Cerdà-Costa N., Esteras-Chopo A., Aviles F.X., Serrano L., Villegas V. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. J Mol Biol 2007, 366:1351-1353.
32. Rigacci S., Bucciantini M., Relini A., Pesce A., Gliozzi A., Berti A., et al. The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies. Biophys J 2008, 94:3635-3646.
33. Porat Y., Abramowitz A., Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 2006, 67:27-37.
34. Visioli F., Bellomo G., Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998, 247:60-64.
35. Mishra R., Sellin D., Radovan D., Gohlke A., Winter R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem 2009, 10:445-449.
36. Tracz S.M., Abedini A., Driscoll M., Raleigh D.P. Role of aromatic interactions in amyloid formation by peptides derived from human amylin. Biochemistry 2004, 43:15901-15908.
37. Vissers M.N., Zock P.L., Roodengburg A.J.C., Leenen R., Katan M.B. Olive oil phenols are adsorbed in humans. J Nutr 2002, 132:409-417.
38. Corona G., Tzounis X., Dessì M.A., Deiana M., Debnam E.S., Visioli F., et al. The fate of olive oil polyphenols in the gastrointestinal tract: implications of gastric and colonic microflora-dependent biotransformation. Free Radic Res 2006, 40:647-658.